Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially preterm babies and infants under six months old. The younger the child, the ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Last year, a prenatal maternal vaccine (Avrexy) and a long-lasting monoclonal antibody called nirsevimab were approved for ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

A new free vaccine program from the Federal Government is expected to protect pregnant women and babies from the ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

TAYLOR — State officials joined area pharmacists Thursday morning to tout the value of vaccines as the holiday season ...